Wendy Balemans
About
In The Last Decade
Wendy Balemans
42 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 2.7k
- Oncology 1.1k
- Genetics 899
- Orthopedics and Sports Medicine 891
- Rheumatology 403
Countries citing papers authored by Wendy Balemans
This map shows the geographic impact of Wendy Balemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Balemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Balemans more than expected).
Fields of papers citing papers by Wendy Balemans
This network shows the impact of papers produced by Wendy Balemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Balemans. The network helps show where Wendy Balemans may publish in the future.
Co-authorship network of co-authors of Wendy Balemans
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Balemans. A scholar is included among the top collaborators of Wendy Balemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Balemans. Wendy Balemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 113 | |
| 3 | 262 | |
| 4 | 5 | |
| 5 | An autosomal dominant high bone mass phenotype in association with craniosynostosis in an extended family is caused by an LRP5 missense mutation | 3 |
| 6 | 100 | |
| 7 | 55 | |
| 8 | 67 | |
| 9 | 35 | |
| 10 | 41 | |
| 11 | Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) breakdown → | 873 |
| 12 | 29 | |
| 13 | 79 | |
| 14 | 10 | |
| 15 | 97 | |
| 16 | 1 | |
| 17 | Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea. | 18 |
| 18 | Localisation of the gene for Van Buchem disease to a candidate region of less than 1 cM on chromosome 17. | 1 |
| 19 | 24 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.